Global Controlled Release Drug Delivery Market Research Report - Global Forecast till 2027

Global Controlled Release Drug Delivery Market Research Report, by Route of administration (Transdermal, Oral), Release Mechanism (Polymer-based, Micro reservoir Partition), Products (Metered Dose Inhalers), End User (Hospital)— Forecast till 2027

ID: MRFR/Pharma/5330-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario:


The Global Controlled Release Drug Delivery Market was estimated USD 31.96 billion in 2017 and expected to reach USD 70.15 billion by 2023 at a CAGR of 14.0 % during the forecast period. Controlled Release Drug Delivery technology is using to provide a uniform amount of drug doses for specific treatment. The demand for controlled release drug delivery system is increasing owing to the growing geriatric and pediatric population, the rising prevalence of chronic diseases, and increasing government regulation to prevent overdose effects. Few of the advantages related to controlled release drug delivery are it helps to reduce toxins accumulation due to heavy dose, stabilizes medical condition, decreases in the frequency of drug administration, and also improves patient compliance. Along with the application, this system has some limitations associated with it which hinders the market growth. The limitation is higher cost compare to the conventional method, the possibility of less accuracy in adjusting the dosage, and controlled release drug delivery system is not suitable for all drugs.


 Segmentation:


The Global Controlled Release Drug Delivery Market is segmented on the basis of route of administration, release mechanism, products, and End Users.


By route of administration the market is segmented into oral, injectable, ocular, nasal, topical and implantable. The injectable is sub-segmented into targeted delivery, transmucosal, and transdermal. On the basis of the release mechanism, the market is segmented into polymer-based drug delivery systems, micro-reservoir partition-controlled drug delivery systems, feedback-regulated drug delivery systems, activation modulated drug delivery systems, and chemically activated controlled drug delivery systems. The activation modulated drug delivery systems are sub-segmented into osmotic pressure activated drug delivery, hydrodynamic pressure activated drug delivery, vapor pressure activated drug delivery, mechanically activated drug, magnetically activated drug. The chemically activated controlled drug delivery systems are sub-segmented into pH-activated drug delivery, hydrolysis activated drug delivery, enzyme activated drug delivery.


By product, the market is segmented into metered dose inhalers, needle-free injectors, auto-injectors, nasal sprays, transdermal patches, nebulizers, infusion pumps, drug-eluting stents, sustained release, and ocular implants. By end user, the market is segmented into hospital and clinics, personal use, research centers, and others.    


On the basis of region, the Global Controlled Release Drug Delivery Market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.


 Key Players:


Some of the key players in the Global Controlled Release Drug Delivery Market are Depomed, Inc. (US), Coating Place, Inc.(US), Corium International Inc.(US), Alza Corporation (Johnson & Johnson)(US), Pfizer Inc.(US), SKY Pharmaceuticals Pvt. Ltd.(China), AstraZeneca (US),Biogen (US), GlaxoSmithKline (UK), Novartis (UK), Allergan (‎Ireland), Collegium Pharmaceutical (US) and Others.
Regional Market Summary
Global Controlled Release Drug Delivery Market Share (%), by Region, 2017
Controlled Release Drug Delivery Market


Sources: National Cancer Institute, Cancer Research UK, the American Cancer Society, Inc, US Department of Health and Human Services National Institutes of Health


It is estimated that North America is expected to dominate the Global Controlled Release Drug Delivery Marketduring the forecasted period owing to the increasing prevalence of various disease such as gastrointestinal diseases (Crohn's disease and ulcerative colitis), Alzheimer’s etc., advance infrastructure in pharmaceutical industry, increasing research and development activity, and presence of big pharmaceutical companies in the region. According to the Centers for Disease Control and Prevention, estimated that 3 million of the US adults were diagnosed with inflammatory bowel disease (either ulcerative colitis or Crohn’s disease) in 2015. Such a high number of patients with gastrointestinal diseases may increase the demand for controlled release drug.


 Europe stood second largest in the Controlled Release Drug Delivery Market due to the increasing prevalence of respiratory diseases, high blood pressure or hypertension among the population. The Public Health England 2017 reported that around 2.1 million of the population below the age of 45 had high blood pressure in England in 2015. The increasing prevalence of hypertension and the cases of chronic diseases can boost the market during the forecasted period. 


 Asia-Pacific was anticipated to be the rapidly growing region for the controlled release drug delivery market. The market is likely to witness growth due to the increase in geriatric and pediatric population resulting in increasing demand for controlled doses to reduce the side effects and toxicity level in the patients. These factors may contribute to the market growth of controlled release drug in Asia-Pacific countries.


The Middle East and Africa holds low share in the global controlled release drug delivery market due to a fewer pharmaceutical industries with manufacturing units, low expenditure on healthcare, less awareness about the diseases and its treatments. However, the market is expected to observer growth due to increasing government funding on healthcare in the Middle East region.


 Intended Audience:



  • Government and private laboratories

  • Hospitals and Clinics

  • Research Centers

  • Pharmaceutical manufacturers

  • Biopharmaceutical companies

  • Contract laboratories

  • Authorities


Market Segmentation and Key Market Players:


 Global Controlled Release Drug Delivery Market, by Route of Administration:



  • Oral

  • InjectableTargeted Delivery

    • Transmucosal

    • Transdermal

    • Ocular



  • Nasal

  • Topical

  • Implantable


Global Controlled Release Drug Delivery Market, by Release Mechanism:    



  • Polymer-based Drug Delivery Systems

  • Micro reservoir Partition Controlled Drug Delivery Systems

  • Feedback Regulated Drug Delivery Systems

  • Activation Modulated Drug Delivery Systems

    • Osmotic Pressure Activated drug delivery

    • Hydrodynamic Pressure Activated drug delivery

    • Vapor Pressure Activated drug delivery

    • Mechanically Activated drug

    • Magnetically Activated drug



  • Chemically Activated Controlled Drug Delivery Systems

    • pH Activated Drug Delivery

    • Hydrolysis Activated Drug Delivery

    • Enzyme Activated Drug Delivery




Global Controlled Release Drug Delivery Market, by Products:



  • Metered Dose Inhalers,

  • Needle-Free injectors

  • Auto-injectors

  • Nasal sprays

  • Transdermal Patchez

  • Nebulizers

  • Infusion Pumps

  • Drug Eluting Stents

  • Sustained Release

  • Ocular Implants


 Global Controlled Release Drug Delivery Market, by End Users:



  • Hospital and Clinics

  • Personal Use

  • Research Centers

  • Others


Global Controlled Release Drug Delivery Market, by Region:



  • Americas

  • Europe

  • Asia-Pacific

  • Middle East & Africa



TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Route of Administration Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Controlled Release Drug Delivery Market, by Route of Administration

6.1 Introduction

6.2 Oral

6.3 Injectable

6.3.1 Targeted Delivery

6.3.2 Transmucosal

6.3.3 Transdermal

6.4 Ocular

6.5 Nasal

6.6 Topical

6.7 Implantable

Chapter 7. Global Controlled Release Drug Delivery Market, by Release Mechanism

7.1 Introduction

7.2 Polymer-based Drug Delivery Systems

7.3 Micro reservoir Partition Controlled Drug Delivery Systems

7.4 Feedback Regulated Drug Delivery Systems

7.5 Activation Modulated Drug Delivery Systems

7.5.1 Osmotic Pressure Activated drug delivery

7.5.2 Hydrodynamic Pressure Activated drug delivery

7.5.3 Vapor Pressure Activated drug delivery

7.5.4 Mechanically Activated drug

7.5.5 Magnetically Activated drug

7.6 Chemically Activated Controlled Drug Delivery Systems

7.6.1 pH Activated Drug Delivery

7.6.2 Hydrolysis Activated Drug Delivery

7.6.3 Enzyme Activated Drug Delivery

Chapter 8. Global Controlled Release Drug Delivery Market, by Products

8.1 Metered Dose Inhalers,

8.2 Needle-Free injectors

8.3 Auto-injectors

8.4 Nasal sprays

8.5 Transdermal Patchez

8.6 Nebulizers

8.7 Infusion Pumps

8.8 Drug-Eluting Stents

8.9 Sustained Release

8.10 Ocular Implants

Chapter 9. Global Controlled Release Drug Delivery Market, by End User

9.1 Introduction

9.2 Hospital and Clinics

9.3 Personal Use

9.4 Research Centers

9.5 Others

Chapter 10. Global Controlled Release Drug Delivery Market, by Region

10.1 Introduction

10.2 America

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

10.6. Company Landscape

10.6.1 Introduction

10.6.2 Market Share Analysis

10.6.3 Key Development & Strategies

10.6.3.1 Key Developments

Chapter 11 Company Profiles

11.1 DEPOMED, INC.

11.1.1 Company Overview

11.1.2 Type Overview

11.1.3 Financials

11.2.4 Key Developments

11.1.5 SWOT Analysis

11.2 Coating Place, Inc

11.2.1 Company Overview

11.2.2 Type Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Corium International Inc.

11.3.1 Company Overview

11.3.2 Type Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Alza Corporation (Johnson & Johnson)

11.4.1 Company Overview

11.4.2 Type/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 PFIZER INC.

11.5.1 Company Overview

11.5.2 Type Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 SKY Pharmaceuticals Pvt. Ltd.

11.6.1 Company Overview

11.6.2 Type Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 AstraZeneca

11.7.1 Overview

11.7.2 Type Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 BIOGEN

11.8.1 Overview

11.8.2 Type Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 GlaxoSmithKline

11.9.1 Overview

11.9.2 Type Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Novartis

11.10.1 Overview

11.10.2 Type Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Allergan

11.11.1 Overview

11.11.2 Type Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Collegium Pharmaceutical

11.11.1 Overview

11.11.2 Type Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.13 Others

Chapter 12 Appendix

LIST OF TABLES

Table 1 Global Controlled Release Drug Delivery Market Industry Synopsis, 2020–2027

Table 2 Global Controlled Release Drug Delivery Market Estimates & Forecast, 2020–2027, (USD Million)

Table 3 Global Controlled Release Drug Delivery Market, by Region, 2020–2027, (USD Million)

Table 4 Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)

Table 5 Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)

Table 6 Global Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million)

Table 7 Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)

Table 8 North America: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)

Table 9 North America: Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)

Table 10 North America: Global Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million)

Table 11 North America: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)

Table 12 US: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)

Table 13 US: Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)

Table 14 US: Global Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million)

Table 15 US: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)

Table 16 Canada: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)

Table 17 Canada: Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)

Table 18 Canada: Global Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million)

Table 19 Canada: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)

Table 20 South America: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)

Table 21 South America: Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)

Table 22 South America: Global Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million

Table 23 South America: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)

Table 24 Europe: Global Controlled Release Drug Delivery Market, Route of Administration, 2020–2027, (USD Million)

Table 25 Europe: Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)

Table 26 Europe: Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million)

Table 27 Europe: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)

Table 28 Western Europe: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)

Table 29 Western Europe: Global Controlled Release Drug Delivery Market, by Release Mechanism ,2020 –2027, (USD Million)

Table 30 Western Europe: Global Controlled Release Drug Delivery Market, by Products,2020 –2027, (USD Million)

Table 31 Western Europe: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)

Table 32 Eastern Europe: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)

Table 33 Eastern Europe: Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)

Table 34 Eastern Europe: Global Controlled Release Drug Delivery Market, by Patent Type, 2020 –2027, (USD Million)

Table 35 Eastern Europe: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)

Table 36 Asia-Pacific: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)

Table 37 Asia-Pacific: Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)

Table 38 Asia-Pacific: Global Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million)

Table 39 Asia-Pacific: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)

Table 40 Middle East & Africa: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)

Table 41 Middle East & Africa: Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)

Table 42 Middle East & Africa: Global Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million)

Table 43 Middle East & Africa: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Products

Figure 2 Market structure for the Global Controlled Release Drug Delivery Market

Figure 3 Market Dynamics for the Global Controlled Release Drug Delivery Market

Figure 4 Global Controlled Release Drug Delivery Market Share, by Route of Administration 2020

Figure 5 Global Controlled Release Drug Delivery Market Share, by Release Mechanism, 2020

Figure 6 Global Controlled Release Drug Delivery Market Share, by Products, 2020

Figure 7 Global Controlled Release Drug Delivery Market Share, by End-User, 2020

Figure 8 Global Controlled Release Drug Delivery Market Share, by Region, 2020

Figure 9 North America Global Controlled Release Drug Delivery Market Share, by Country, 2020

Figure 10 Europe Prescribed Health Apps Share, by Country, 2020

Figure 11 Asia-Pacific Global Controlled Release Drug Delivery Market Share, by Country, 2020

Figure 12 Middle East & Africa Global Controlled Release Drug Delivery Market Share, by Country, 2020

Figure 13 Global Controlled Release Drug Delivery Market: Company Share Analysis, 2020 (%)

Figure 14 DEPOMED, INC.: Key Financials

Figure 15 DEPOMED, INC.: Segmental Revenue

Figure 16 DEPOMED, INC.: Geographical Revenue

Figure 17 Coating Place, Inc: Key Financials

Figure 18 Coating Place, Inc: Segmental Revenue

Figure 19 Coating Place, Inc: Geographical Revenue

Figure 20 Corium International Inc.: Key Financials

Figure 21 Corium International Inc.: Segmental Revenue

Figure 22 Corium International Inc.: Geographical Revenue

Figure 23 Alza Corporation (Johnson & Johnson): Key Financials

Figure 24 Alza Corporation (Johnson & Johnson): Segmental Revenue

Figure 25 Alza Corporation (Johnson & Johnson): Geographical Revenue

Figure 26 PFIZER INC.: Key Financials

Figure 27 PFIZER INC.: Segmental Revenue

Figure 28 PFIZER INC.: Geographical Revenue

Figure 29 SKY Pharmaceuticals Pvt. Ltd.: Key Financials

Figure 30 SKY Pharmaceuticals Pvt. Ltd.: Segmental Revenue

Figure 31 SKY Pharmaceuticals Pvt. Ltd.: Geographical Revenue

Figure 32 AstraZeneca: Key Financials

Figure 33 AstraZeneca: Segmental Revenue

Figure 34 AstraZeneca: Geographical Revenue

Figure 35 Biogen: Key Financials

Figure 36 Biogen: Segmental Revenue

Figure 37 Biogen: Geographical Revenue

Figure 38 GlaxoSmithKline: Key Financials

Figure 39 GlaxoSmithKline: Segmental Revenue

Figure 40 GlaxoSmithKline: Geographical Revenue

Figure 41 Novartis: Key Financials

Figure 42 Novartis: Segmental Revenue

Figure 43 Novartis: Geographical Revenue

Figure 44 Allergan: Key Financials

Figure 45 Allergan: Segmental Revenue

Figure 46 Allergan: Geographical Revenue

Figure 47 Collegium Pharmaceutical: Key Financials

Figure 48 Collegium Pharmaceutical: Segmental Revenue

Figure 49 Collegium Pharmaceutical: Geographical Revenue